Zielblutdruck bei Nierenerkrankungen

Im November 2017 wurden neue Leitlinien zur Diagnostik und Therapie der arteriellen Hypertonie von der American Heart Association und dem American College of Cardiology veröffentlicht. Diese neuen US-Leitlinien revolutionieren die Definition der arteriellen Hypertonie und die Empfehlungen zum Zielblutdruck [1].

• Literatur

• 1 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; Nov 7. pii S0735–1097 (17) 41519-1 doi: 10.1016/j.jacc.2017.11.006 [Epub ahead of print]
• 2 Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int Suppl 2012; 2: 337-414
• 3 SPRINT Research Group. Wright JT, Williamson JD, Whelton PK. et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015; 373: 2103-2116 doi:10.1056/NEJMoa1511939
• 4 ACCORD Study Group. Cushman WC, Evans GW, Byington RP. et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-1585 doi:10.1056/NEJMoa1001286
• 5 Obi Y, Kalantar-Zadeh K, Shintani A. et al. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial. J Intern Med 2018; 283: 314-327 doi: 10.1111/joim.12701
• 6 Beddhu S, Rocco MV, Toto R. et al. SPRINT Research Group. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. Ann Intern Med 2017; 167: 375-383 doi:10.7326/M16–2966
• 7 Drawz PE, Pajewski NM, Bates JT. et al. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension 2017; 69: 42-50 doi:10.1161/HYPERTENSIONAHA.116.08076
• 8 Sarafidis PA, Persu A, Agarwal R. et al. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). J Hypertens 2017; 35: 657-676 doi:10.1097/HJH.0000000000001283
• 9 Krämer BK, Hausberg M, Sanner B. et al. für die Task Force Wissenschaftliche Stellungnahmen und Leitlinien der DHL®. [Blood Pressure Measurement and Treatment Targets: Position Paper of the DHL® Task Force Scientific Statements and Guidelines]. Dtsch Med Wochenschr 2017; 142: 1446-1447 doi:10.1055/s-0043–117070